英立达援助
Published by:
Cancer Foundation of china
Description
英立达患者援助项目是辉瑞公司发起的旨在帮助符合项目医学和经济标准的贫困、低收入晚期肾细胞癌患者，以减轻他们的经济负担。
中国癌症基金会接受辉瑞投资有限公司捐赠的英立达药品，并负责在中国大陆开展项目的具体实施。
此项应用是建立在中国癌症基金会英立达患者援助项目流程基础上，为晚期肾细胞癌患者、指定医生、指定药师、协管员等特定人群设定独立的场景开展项目工作。患者可更方便、快捷的了解项目相关内容并可在线预约，随时了解本人申请及领药情况。指定医生、药师、协管员通过本应用实时掌握患者信息，从而更加高效的参与对患者的管理和服务。
目前处于测试阶段，请大家及时关注更新。
中国癌症基金会接受辉瑞投资有限公司捐赠的英立达药品，并负责在中国大陆开展项目的具体实施。
此项应用是建立在中国癌症基金会英立达患者援助项目流程基础上，为晚期肾细胞癌患者、指定医生、指定药师、协管员等特定人群设定独立的场景开展项目工作。患者可更方便、快捷的了解项目相关内容并可在线预约，随时了解本人申请及领药情况。指定医生、药师、协管员通过本应用实时掌握患者信息，从而更加高效的参与对患者的管理和服务。
目前处于测试阶段，请大家及时关注更新。
Screenshots
英立达援助 FAQ
-
Is 英立达援助 free?
Yes, 英立达援助 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 英立达援助 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 英立达援助 cost?
英立达援助 is free.
-
What is 英立达援助 revenue?
To get estimated revenue of 英立达援助 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Taiwan yet.
Ratings History
英立达援助 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
英立达援助 Installs
Last 30 days
英立达援助 Revenue
Last 30 days英立达援助 Revenue and Downloads
Gain valuable insights into 英立达援助 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
-
Cancer Foundation of china
- Languages
- English
- Recent release
- 2.0 (3 years ago )
- Released on
- Jun 19, 2017 (7 years ago )
- Also available in
- China, Türkiye, Taiwan, United States, Indonesia
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.